A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Range Unmanned Surface Vessel program to the major capability acquisition pathway in fiscal year 2027 following a decision to terminate a middle tier acquisition rapid prototyping effort, according to ...